Platelet membrane glycoproteins: A look back into the past and a view to the future

 

• References

• 1 Sheppard BL, French JE. Platelet adhesion in rabbit arteries observed by scanning and transmission electron microscopy. Nature 1970; 225: 1054-1055.
• 2 Behnke O. Electron microscopical observations on the surface coating of human blood platelets. J Ultra-struct Res 1968; 24: 51-69.
• 3 Nurden A, Phillips DR, George JN. Platelet membrane glycoproteins: Historical perspectives. J Thromb Haemost 2006; 4: 3-9.
• 4 Marcus AJ, Ullman HL, Safier LB. Studies on human platelet gangliosides. J Clin Invest 1972; 51: 2602-2612.
• 5 Pepper DS, Jamieson GA. Studies on glycoproteins. 3. Isolation of sialyglycopeptides from human platelet membranes. Biochemistry 1969; 8: 3362-3369.
• 6 Pepper DS, Jamiseon GA. Isolation of a macroglycopeptide from human platelets. Biochemistry 1970; 9: 3706-3713.
• 7 Barber AJ, Jamieson GA. Isolation of glycopep-tides from low-and high-density platelet membranes. Biochemistry 1971; 10: 4711-4717.
• 8 Nurden AT. Platelet macroglycopeptide. Nature 1974; 251: 151-153.
• 9 Nachman RL, Ferris B. Studies on the proteins of human platelet membranes. J Biol Chem 1972; 247: 4468-4475.
• 10 Phillips DR. Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry 1972; 11: 4582-4588.
• 11 Nachman RL, Hubbard A, Ferris B. Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem 1973; 248: 2928-2936.
• 12 Caen JP, Castaldi PA, Leclerc JC. et al. Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann’s thrombasthenia. Am J Med 1966; 41: 4-26.
• 13 Born GVR, Cross MJ. Effects of inorganic ions and of plasma proteins on the aggregation of blood platelets by adenosine diphosphate. J Physiol 1964; 170: 397-414.
• 14 Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. Br J Haematol 1974; 28: 253-260.
• 15 Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature 1975; 255: 720.
• 16 Bernard J, Caen J, Jeanneau C. et al. La dystrophie thrombocytaire hémorragipare. ActHématol 1974; 8: 3-14.
• 17 Grottum KA, Solum NO. Congenital thrombocytopenia with giant platelets: a defect in the platelet membrane. Br J Haematol 1969; 16: 277-290.
• 18 Bithell TC, Parekh SJ, Strong RR. Platelet-function studies in the Bernard-Soulier syndrome. Ann NY Acad Sci 1972; 201: 145-159.
• 19 Weiss HJ, Tschopp TB, Baumgartner HR. et al. Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium-further implications on the role of the von Willebrand factor in hemostasis. Am J Med 1974; 57: 920-928.
• 20 Phillips DR, Jenkins CS, Luscher EF. et al. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature 1975; 257: 599-600.
• 21 Caen JP, Nurden AT, Jeanneau C. et al. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to sub-endothelium and with the factor VIII von Willebrand protein. J Lab Clin Med 1976; 87: 586-593.
• 22 Hagen I, Bjerrum OJ, Solum NO. Characterization of human platelet proteins solubilized with Triton X-100 and examined by crossed immunoelectrophoresis. Reference patterns of extracts from whole platelets and isolated membranes. Eur J Biochem 1979; 99: 9-22.
• 23 Hagen I, Nurden AT, Bjerrum OJ. et al. Immuno-chemical evidence for protein abnormalities from patients with Glanzmann’s thrombasthenia and Bernard-Soulier syndrome. J Clin Invest 1980; 65: 722-729.
• 24 Kunicki TJ, Nurden AT, Pidard D. et al. Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed immunoelectrophoresis. Blood 1981; 58: 1190-1199.
• 25 Rosa JP, Kieffer N, Didry D. et al. The human platelet membrane glycoprotein complex GPIIb-IIIa expresses antigenic sitesnot exposed on the dissociated glycoproteins. Blood 1984; 64: 1246-1253.
• 26 Phillips DR, Poh Agin PP. Platelet membrane defects in Glanzmann’s thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest 1977; 60: 535-545.
• 27 Nurden AT, Dupuis D, Kunicki TJ, Caen JP. Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest 1981; 67: 1431-1440.
• 28 Clemetson KJ, McGregor JL, James E. et al. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982; 70: 304-311.
• 29 Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-5363.
• 30 Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1401.
• 31 Coller BS, Peerschke EI, Scudder LE. et al. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombas-thenic-like state in normal platelets and binds to glyco-proteins IIb and/or IIIa. J Clin Invest 1983; 72: 325-338.
• 32 Gartner TK, Williams DC, Minion FC. et al. Thrombin-induced platelet aggregation is mediated by a platelet plasma- membrane-bound lectin. Science 1978; 200: 1281-1283.
• 33 Phillips DR, Jennings LK, Edwards HH. Identification of membrane proteins mediating the interaction of human platelets. J Cell Biol 1980; 86: 77-86.
• 34 Ginsberg MH, Painter RG, Forsyth J. et al. Thrombin increases expression of fibronectin on the platelet surface. Proc Natl Acad Sci USA 1980; 77: 1049-1053.
• 35 George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 1984; 311: 1084-1098.
• 36 Hourdillé P, Hasitz M, Belloc F. et al. Immunocyto-chemical study of the binding of fibrinogen and thrombospondin to ADP-and thrombin-stimulated human platelets. Blood 1985; 65: 912-920.
• 37 Legrand C, Dubernard V, Nurden AT. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated platelets. Blood 1989; 73: 1226-1234.
• 38 Shattil SJ, Hoxie JA, Cunningham M. et al. Changes in the platelet membrane glycoprotein IIb. IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-11114.
• 39 Heilmann E, Hourdille P, Pruvost A. et al. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins. Arterioscler Thromb 1991; 11: 704-718.
• 40 Coller BS. Anti-GPIIb/IIIa drugs: Curent strategies and future directions. Thromb Haemost 2001; 86: 427-443.
• 41 Ruggeri ZM, Orie JN, Habermann R. et al. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006; 108: 1903-1910.
• 42 Matuskova J, Chauhan AK, Cambien B. et al. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol 2006; 26: 1391-1396.
• 43 Xiao T, Takagi J, Coller BS. et al. Structural basis for allosteryin in tegrins and binding to fibrinogen-mimetic the rapeutics. Nature 2004; 432: 59-67.
• 44 Wegener KL, Partridge AW, Han J. et al. Structural basis of integrin activation by talin. Cell 2007; 128: 171-182.
• 45 Goschnick MW, Lau LM, Wee JL. et al. Impaired ‘outside-in’ integrin αIIbβ3 signaling and thrombus stability in TSSC6-deficient mice. Blood 2006; 108: 1911-1918.
• 46 Arias-Salgado EG, Haj F, Dubois C. et al. PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol 2005; 170: 837-845.
• 47 Prevost N, Woulfe DS, Jiang H. et al. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci USA 2005; 102: 9820-9825.
• 48 Nanda N, André P, Bao M. et al. Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. Blood 2005; 106: 3028-3034.
• 49 Zhu L, Bergmeier W, Wu J. et al. Regulated surface expression and shedding support a dual role for Semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci USA 2007; 104: 1621-1626.